SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-12-002680
Filing Date
2012-09-19
Accepted
2012-09-19 12:38:49
Documents
8
Effectiveness Date
2012-09-19

Document Format Files

Seq Description Document Type Size
1 S-8 zk1212034.htm S-8 91805
2 ARTICLES OF ASSOCIATION OF THE REGISTRANT, AS AMENDED. exhibit_3-1.htm EX-3.1 200336
3 OPINION OF YIGAL ARNON & CO., JERUSALEM, ISRAEL, AS TO THE LEGALITY OF THE SECUR exhibit_5-1.htm EX-5.1 10805
4 OPINION OF MORRISON & FOERSTER LLP, NEW YORK, NEW YORK, AS TO THE LEGALITY OF TH exhibit_5-2.htm EX-5.2 17261
5 CONSENT OF YIGAL ARNON & CO., JERUSALEM, ISRAEL exhibit_23-3.htm EX-23.3 5175
6 img1.jpg GRAPHIC 8122
7 img2.jpg GRAPHIC 3675
8 img3.jpg GRAPHIC 4473
  Complete submission text file 0001178913-12-002680.txt   349230
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-183976 | Film No.: 121099307
SIC: 2834 Pharmaceutical Preparations